HLL Lifecare Limited (HLL), a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, is a global provider of high-quality healthcare products & services. 

Cliantha Research, a full-service Clinical Research Organization (CRO), is a leading provider of Clinical research services, based in Ahmedabad, India. Cliantha’s motto is Science with Integrity. Cliantha has fifteen years of impeccable regulatory history with USFDA, WHO, MHRA, Health Canada, AGES, AEMPS, MCC, MOH, ANSM, MOPH, ANVISA, CAP, and NABL.  

Post : Business Development Team

National Health Mission, Health Department Zilla Parishad, Hingoli Mobile Medical Unit Recruitment Notification on Daily Basis.

Post : Pharmacist

IIT Delhi lays a strong emphasis on the sponsored research and industrial interaction. The Institute has not only given due emphasis to investigation of problem of direct relevance to the needs of the country through time bound sponsored and consultancy project aimed at solving live industrial problems, but also has given special attention to emerging areas internationally.

The JAMP group is a proud Canadian owned company with its international headquarters located in Boucherville, 20 minutes from downtown Montreal, Quebec, Canada. The JAMP Pharma Group is active in all sectors of the pharmaceutical industry with our JAMP Pharma Generics, Orimed branded products, our Wampole and Laboratoire Suisse natural health supplements and our Cosmetic Import beauty and personal care products. The JAMP Pharma Group has also made a major investment in biosimilars which is one of the fastest growing markets in the pharmaceutical industry.

Acute graft-versus-host disease (aGVHD) is a medical condition that occurs when donor immune cells attack the recipient's tissues after an allogeneic hematopoietic stem cell transplantation (allo-HCT). The pathogenesis of aGVHD is influenced by gut dysbiosis and Enterococcus domination. Researchers from Japan recently identified a bacteriophage-derived enzyme called endolysin capable of targeting biofilms formed by Enterococcus faecalis. Their findings offer hope for tailored interventions in allo-HCT.